INTRODUCTION {#s1}
============

Congenital hypothyroidism (CH) is an endocrine disorder that may result from disrupted thyroid hormone (TH) synthesis (15--20% of all cases) or impaired development of the thyroid gland \[thyroid dysgenesis (TD)\] (80% of all cases) ([@BIO037655C42]). CH is the most prevalent congenital endocrine disorder and is believed to be one of the most preventable causes of mental retardation ([@BIO037655C11]; [@BIO037655C55]; [@BIO037655C61]). Indeed, in infants younger than 3 months of age, neurological damage progressively worsens with delay in starting treatment ([@BIO037655C80]). Mutations in the NADPH oxidase *DUOX2* and, to a lesser extent, *DUOX1* have been associated with dyshormonogenesis in CH patients ([@BIO037655C4]; [@BIO037655C51]). DUOX1 and DUOX2 generate hydrogen peroxide (H~2~O~2~), which is a crucial electron acceptor during thyroid peroxidase-catalysed iodination and coupling reactions occurring while TH synthesis is underway ([@BIO037655C16]; [@BIO037655C21]). H~2~O~2~ production is a limiting step in TH biosynthesis. The main source of H~2~O~2~ in the thyroid is DUOX2 in conjunction with its maturation factor DUOX2A, both of which are located at the apical surface of the thyroid follicular cells, thyrocytes. DUOX2-mediated H~2~O~2~ acts as a thyroperoxidase (TPO) co-substrate, rapidly oxidising iodine and resulting in its covalent binding to the tyrosine residues of thyroglobulin in the follicular lumen. This produces monoiodotyrosine (MIT) and diiodotyrosine (DIT), in the thyroglobulin molecule, which undergo coupling to give the THs triiodothyronine (T~3~) and thyroxine (T~4~) ([@BIO037655C9]; [@BIO037655C52]; [@BIO037655C72]). A negative feedback loop is in charge of thyroid size and function. Thyrocytes secrete T~3~ and T~4~ and these inhibit the production of the thyroid-stimulating hormone (TSH) via the anterior pituitary thyrotropes ([@BIO037655C20]). Thyrocytes respond to limiting physiological stimuli by way of hypertrophy and proliferation. This is a direct response to compensate for diminishing THs in conditions including, but not limited to, iodine deficiency, exposure to anti-thyroid drugs and punctuated production of reactive oxygen species (ROS). It has been shown that early initiation of TH treatment (within 3 weeks post-partum) leads to normal IQ and physical growth and correlates with excellent prognoses ([@BIO037655C3]; [@BIO037655C13]; [@BIO037655C60]; [@BIO037655C63]). Expectedly then, if treatment is delayed beyond 4 weeks, individuals become increasingly prone to mental retardation and incomplete physical growth ([@BIO037655C24]; [@BIO037655C86]). To date, various approaches have been adopted to induce hypothyroidism in animal models, including surgical removal of the thyroid gland, thyroid gland removal via radioactive iodine isotope (^131^I), dietary restriction of iodine, and goitrogen administration ([@BIO037655C2]). We present here a zebrafish model of CH, which exhibits several phenotypes associated with CH in humans, including growth retardation. Interestingly, while CH zebrafish display growth retardation initially, they are able to reach normal size eventually without the need for pharmacological intervention. The additional external and internal phenotypes associated with hypothyroidism are restored upon treatment with T~4~, including restoration of reproductive function, even when treatment is applied during adulthood.

RESULTS {#s2}
=======

Molecular characterisation of *duox* mutant alleles {#s2a}
---------------------------------------------------

Duox is a member of the NADPH oxidase (NOX) family of enzymes. Seven NOX family members are present in the human genome: NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1 and DUOX2, and their primary function is to produce reactive oxygen species (ROS). All NOX enzymes are transmembrane proteins, exhibiting structural and functional conservation. They participate in electron transport across biological membranes, effecting the reduction of molecular oxygen to superoxide ([@BIO037655C6]). All NOX enzymes share conserved structural domains, including intracellular C-terminal tails containing NADPH and FAD binding sites and six transmembrane domains anchoring four highly conserved heme-binding histidines. DUOXes have an additional transmembrane domain, an extracellular N-terminal domain with peroxidase homology and two EF Ca^2+^ binding hands within their first intracellular loop ([Fig. 1](#BIO037655F1){ref-type="fig"}A) ([@BIO037655C59]). The zebrafish genome encodes a single *duox* gene, rather than two *DUOX* paralogues present in humans (*DUOX1* and *DUOX2*) and lacks a *NOX3* orthologue ([@BIO037655C40]). In zebrafish *duox* is located on chromosome 25 and encodes a 1528 amino acid protein. In order to investigate the function of *duox* in zebrafish, we obtained two nonsense mutation alleles, which arose from a large-scale ENU mutagenesis screen ([@BIO037655C41]). One allele, *duox sa9892*, contains a nonsense mutation in exon 21, resulting in a C\>T change ([Fig. 1](#BIO037655F1){ref-type="fig"}B) and a premature stop codon (TAG) after the 944th amino acid; the second allele, *duox sa13017*, contains a nonsense mutation in exon 23, resulting in a C\>T change ([Fig. 1](#BIO037655F1){ref-type="fig"}C) creating a premature stop codon (TGA) after the 997th amino acid. Since both these premature codons result in truncations of the Duox protein, including the loss of the two critical C-terminal NADPH and FAD binding sites, they would be expected to be loss-of-function mutations. Genotyping of these alleles can be performed via genomic PCR followed by sequencing of these regions ([Fig. 1](#BIO037655F1){ref-type="fig"}B,C). Fig. 1.**Molecular characterisation** **of *duox* mutant alleles.** Duox is a transmembrane protein belonging to the NADPH oxidase family of enzymes. Duox (A) consists of seven transmembrane domains (2), two EF hands (3), heme (4), FAD domain (5), an NADPH oxidase domain (6) at the C-terminus as well as a peroxidase homology domain (1), thus named Dual oxidase. Characterisation of *duox sa9892* (B) and *duox sa13017* (C), via Sanger sequencing, shows the single nucleotide change C\>T in contrast to a WT reference sequence.

*duox* mutants are growth retarded {#s2b}
----------------------------------

We in-crossed *duox sa9892^+/−^* and *duox sa13017^+/−^* sibling adults and inter-crossed *duox sa9892^+/−^* with *duox sa13017^+/−^* adults to produce a range of wild-type (WT), heterozygous, homozygous mutant and compound heterozygous mutant animals containing both alleles. While the WT, *duox sa9892^+/−^* and *duox sa13017^+/−^* animals were phenotypically indistinguishable, the homozygous mutants of both alleles, and the compound mutants (i.e. *duox sa9892/sa13017)* displayed a number of phenotypes that were distinct from those seen in the WT and heterozygous siblings. The first overtly apparent phenotype exhibited by the *duox sa9892^−/−^*, the *duox sa13017^−/−^* and the trans-heterozygous *duox sa9892/sa13017* mutants was that they were growth retarded. At 3 months of age, the *sa9892^−/−^, sa13017^−/−^* and *sa9892/sa13017* mutant fish were significantly shorter in terms of body length than their WT and heterozygous siblings ([Fig. 2](#BIO037655F2){ref-type="fig"}A--G). At 6 months of age, the *duox sa9892^−/−^* and *sa9892/sa13017* mutant animals caught up in size with their WT and heterozygous siblings. However, the *duox sa13017^−/−^* animals still remained stunted ([Fig. 2](#BIO037655F2){ref-type="fig"}H). Another phenotype suggestive of slowed growth was apparent in the growth and organogenesis of the swim bladder. The swim bladder is a hydrostatic organ, which becomes bi-lobed by 21 dpf ([@BIO037655C85]). We found that the swim bladder in the *duox sa9892^−/−^* animals remained unilobed even at 54 dpf (*n*=9) ([Fig. 2](#BIO037655F2){ref-type="fig"}I,J). Homozygous *duox* mutants also exhibit a delay or absence of development of barbels, which are a set of anterior sensory appendages. Zebrafish develop a short pair of nasal barbels and a long trailing pair of maxillary barbels ([Fig. 2](#BIO037655F2){ref-type="fig"}K,N). These are normally visible by 1 month post-fertilisation and sustained throughout life ([@BIO037655C45]). In all cases, homozygous *duox* mutants lacked barbels at 3 months of age ([Fig. 2](#BIO037655F2){ref-type="fig"}L,O,P). However, between 6 and 10 months of age, maxillary barbels were seen in some older *duox sa9892^−/−^* (five out of 11; see [Fig. 2](#BIO037655F2){ref-type="fig"}M) and *sa9892/sa13017* (two out of 11) animals, but in none of the *sa13017^−/−^* animals (zero out of nine). Fig. 2.***duox* mutants exhibit growth retardation.** Mutants for both alleles as well as compound heterozygotes are shorter than their WT and heterozygous siblings at 3 months (A--G) but catch up by 6 months (H). *sa13017^−/−^* animals are trailing behind even at 6 months (H). Asterisks in G denote statistically significant differences (Bonferroni\'s multiple comparisons test, \*\*\*\**P*\<0.0001) *duox* mutants also have a delay in the inflation of the anterior lobe of the swim bladder (I,J) (white arrowheads indicate lobes). Adults at 3 months old also lack barbels (L--P), which are observed in heterozygous siblings (white arrowheads; K,N). Barbels emerge in some older animals (6 months and older) (white arrowhead, M). External goitres are often visible in young adults (black arrowheads; L,O). Scale bars: 1 mm.

*duox* mutants have dark pigmentation, erythema and ragged fins {#s2c}
---------------------------------------------------------------

Zebrafish are recognisable by their eponymous pattern of five dark blue stripes alternating with four lighter yellow inter-stripes, covering the lateral flanks, and anal and caudal fins ([@BIO037655C67]). The stripes are comprised of black melanophores with a few iridescent iridophores, while the inter-stripes are comprised of yellow and orange xanthophores and numerous iridophores ([@BIO037655C30]). We found that the homozygous *duox* mutants were darker than their WT and heterozygote siblings ([Fig. 3](#BIO037655F3){ref-type="fig"}A--C). The darker pigmentation was associated with the presence of approximately twice the number of melanophores in the homozygous *duox* mutants, relative to their heterozygous and WT siblings ([Fig. 3](#BIO037655F3){ref-type="fig"}D). Conveniently, we also found that the difference in pigmentation was sufficient to allow for phenotypic identification of homozygous *duox* mutants from their heterozygous and WT siblings, with 100% accuracy, as confirmed retrospectively via genotyping. In addition, homozygous *duox* mutants also showed stripe irregularities not seen in WT and heterozygous siblings, such as wavy stripes and stripe discontinuities ([Fig. 3](#BIO037655F3){ref-type="fig"}E,F). Thus, pigmentation differences can be used as a reliable identification method for distinguishing homozygous *duox* mutants from their heterozygous and WT siblings, as early as 60 dpf. Fig. 3.**Adult *duox* mutant zebrafish display an array of visible phenotypes.** (A--C) 5× magnification of flank region showing the distribution of melanophores in WT, *sa9892^+/−^* and *sa989^−/−^* siblings. The apparent abundance of melanophores was statistically significant in *duox* mutants (D). Asterisks denote statistically significant differences (Bonferroni\'s multiple comparisons test, \*\*\*\**P*\<0.0001). *duox* mutants also showed irregularities in stripe pattern in contrast to heterozygous siblings, shown here in a 2× magnification of the flank in *sa9892* siblings (E,F). Craniofacial anomalies were evident among mutants, with frontal height significantly shorter among mutants (G--I) (Bonferroni\'s multiple comparisons test, \**P*\<0.5, \*\**P*\<0.01). Erythema in the thoracic region was prominent among mutants. This was especially noticeable in *nacre* backgrounds (L,N,O). *duox* mutants also suffered from perpetual fin damage, which manifest as ragged margins and tears (S--U). Scale bars: 1 mm.

Less apparent but nevertheless significant were craniofacial anomalies among adult mutants. In particular, we found a significant shortening of the frontal height among the *duox sa9892^−/−^*, *sa13017^−/−^* and *sa9892/sa13017* animals, when compared to their WT and heterozygous siblings ([Fig. 3](#BIO037655F3){ref-type="fig"}G--I). Adding further to the list of phenotypes, we noticed erythema (redness) in the opercular region of mutants ([Fig. 3](#BIO037655F3){ref-type="fig"}J--O). This was especially prominent in background strains that lack melanophores, such as *nacre* and *casper*. The redness was most apparent in juvenile fish.

Finally, the homozygous *duox* mutants often displayed misshapen or damaged fins ([Fig. 3](#BIO037655F3){ref-type="fig"}P--U). We found that the *duox sa9892^−/−^* (15 out of 15), *sa13017^−/−^* (seven out of seven) and *sa9892/sa13017* (19 out of 23) animals displayed damaged fins*.* In many cases this was manifested as vertical (dorsal and anal fin) or horizontal (caudal fin) tears in the fins. In other cases, there were spontaneous losses of portions of fins or ragged fin margins ([Fig. 3](#BIO037655F3){ref-type="fig"}S--U). Damaged fins were noticeable as early as 42 dpf.

Homozygous *duox* mutants are viable but are unable to breed {#s2d}
------------------------------------------------------------

While we found that *duox sa9892^−/−^* and *sa13017^−/−^* mutants reached adulthood, unlike their heterozygous and WT siblings, they were unable to breed. Females, although gravid, were found not to lay eggs regardless of pairing with mutant, heterozygous or WT males. Similarly, mutant males failed to cross with females, regardless of genotype. Furthermore, we noticed that homozygous *duox* mutant females seemed egg-bound, suggesting that they were unable to lay eggs ([Fig. 4](#BIO037655F4){ref-type="fig"}A,B; left panels). We confirmed that females do contain eggs internally via histological sectioning ([Fig. 4](#BIO037655F4){ref-type="fig"}A,B; right panels) as well as via abdominal squeezing to release eggs. Similarly, compound heterozygotes of the two alleles were found to be viable but failed to breed, and the females also became egg bound. Fig. 4.***duox* mutant females are unable to ovulate and become egg bound.** H&E staining of abdominal sections reveals oocytes (A,B). Scale bars: 1 mm.

Homozygous *duox* mutants develop goitres {#s2e}
-----------------------------------------

In addition to the phenotypes described above, we noted that some of the homozygous *duox* mutant adult animals displayed external goitre-like growths in the submandibular area ([Fig. 5](#BIO037655F5){ref-type="fig"}A,B). These external goitre-like growths were observed among adults older than 3 months of age, across all three mutant combinations -- *duox sa9892^−/−^* (11 out of 18), *sa13017^−/−^* (six out of 11) and *sa9892/sa13017* (three out of 22). These richly vascularised growths were variously sized. Additionally, some of the animals also exhibited lateral flaring of opercular flaps ([Fig. 5](#BIO037655F5){ref-type="fig"}C). To confirm whether these goitre-like growths were indeed enlarged thyroids, we fixed and sectioned a subset of *sa9892^−/−^* and *sa9892/sa13017 duox* mutants, along with some of their WT and heterozygous mutant siblings, and performed *in situ* hybridization (ISH) analysis for the expression of *thyroglobulin*, a thyroid marker. The results confirmed that these growths were indeed of thyroid origin ([Fig. 5](#BIO037655F5){ref-type="fig"}D--L). Also, the thyroid hyperplasia was in striking contrast to the size of the thyroids in the WT and heterozygous siblings, where the extent of *thyroglobulin* staining was much smaller and more distinct, presenting as discreet rings confined to the ventral mid-pharyngeal region ([Fig. 5](#BIO037655F5){ref-type="fig"}E,F). Importantly, all mutants had internal thyroid hyperplasias, regardless of the presence or absence of external goiters ([Fig. 5](#BIO037655F5){ref-type="fig"}G--L). Fig. 5.**Homozygous *duox* mutations lead to goitre.** Adult mutant animals exhibit an array of variably sized external goitres (arrowheads; A,B), as well as lateral flaring of opercula (arrowheads; C). When sectioned along the length of the follicular region (dotted area, D) and subjected to ISH for *thyroglobulin*, mutants reveal extensive spread of and ectopic thyroid follicular tissue (G--L), in contrast to the localised, discreet distribution in WT and heterozygous siblings (arrowheads; E,F). Scale bars: 1 mm.

*duox* mutants are in a state of hypothyroidism {#s2f}
-----------------------------------------------

The goitre-like growths, as well as the other phenotypes observed in the homozygous *duox* mutants suggested that the mutants might be exhibiting hypothyroidism. To test whether this might be the case, we assessed the presence of thyroxine (T~4~) in the homozygous *duox* mutants and in their heterozygous and WT siblings via wholemount immunostaining. We found that, while the WT and heterozygous siblings exhibited robust T~4~ staining ([Fig. 6](#BIO037655F6){ref-type="fig"}A--C), *duox sa9892^−/−^* and *sa13017^−/−^* larvae had no detectable T~4~ staining in their thyroids ([Fig. 6](#BIO037655F6){ref-type="fig"}D,E). Consistent with the loss of T~4~ being due to lack of NADPH oxidase activity in the homozygous *duox* mutants, we were able to phenocopy the loss of T~4~ staining in the larvae by treating them with the NADPH oxidase inhibitor, diphenyleneiodonium (DPI) ([Fig. 6](#BIO037655F6){ref-type="fig"}F). Fig. 6.**Hypothyroidism is evident among *duox* mutants.** At 5 dpf, homozygous mutant larvae lack staining for bound T~4~ in the thyroid follicles, based on wholemount fluorescent immunohistochemistry (D,E). This is in sharp contrast to the robust staining observed in WT and heterozygous siblings (A--C). The NADPH oxidase inhibitor DPI successfully phenocopies *duox* mutations in WT larvae, resulting in an absence of T~4~ detection (F). Scale bar: 50 μm.

*duox*-mediated hypothyroidism is responsive to T~4~ treatment {#s2g}
--------------------------------------------------------------

Among humans, CH responds very well to T~4~ treatment, especially when treatment is initiated as soon as hypothyroidism is suspected ([@BIO037655C60]). Here, we decided to ask whether supplementation of the aquarium water with T~4~ could reverse some or all of the phenotypes observed in the homozygous *duox* mutants. We initiated T~4~ (30 nM) treatment of the *duox sa9892^−/−^* and *sa9892^+/−^* animals starting at 11 months of age, when all of the phenotypes described previously were already apparent. We found that most of the phenotypes associated with loss of *duox* function could be reversed by treatment with T~4~. Body pigmentation was the first phenotype to be reversed in the treated animals, such that by 2 weeks after the initiation of treatment the *duox sa9892^−/−^* animals became visibly paler than their untreated *duox sa9892^−/−^* siblings ([Fig. 7](#BIO037655F7){ref-type="fig"}A versus [7](#BIO037655F7){ref-type="fig"}B). The difference in pigmentation was associated with a significant decrease in melanophore density in T~4~-treated homozygous mutant animals when compared to the untreated homozygous mutant animals ([Fig. 7](#BIO037655F7){ref-type="fig"}C--G). Indeed, the density of melanophores in the treated mutants was similar to that seen in untreated or treated heterozygous mutant animals, suggesting a complete rescue ([Fig. 7](#BIO037655F7){ref-type="fig"}C--G). In addition, we found that fin quality improved markedly, with treated mutants showing fuller, unbroken fins compared to the ragged fins of the untreated controls (compare [Fig. 7](#BIO037655F7){ref-type="fig"}A and B). Furthermore, after 8 weeks of T~4~ treatment we were able to rescue breeding behaviour in both sexes. Mutant males and females were able to spawn with WT animals or with each other. These mating episodes resulted in the production of four clutches of eggs in four consecutive weeks. Rescue of fertility was perhaps the most striking outcome of T~4~ treatment. Fig. 7.**T~4~ treatment alleviates phenotypic anomalies in *duox* mutants.** T~4~-treated mutants show an improvement in fin health, compared to untreated mutants (A,B). Pigment changes are evident among T~4~-treated mutants. C--F show a 5× magnification of the distribution of melanophores on the flank region of *sa9892^+/−^* and *sa989^−/−^* siblings, with a significant reduction in melanophore number (G). Asterisks denote statistically significant differences (Bonferroni\'s multiple comparisons test, \*\*\*\**P*\<0.0001). Goitres resolve following T~4~ administration, but small ectopic thyroids are still evident (black arrowheads) (I,J). Scale bars: 1 mm.

Having observed a rescue of most of the phenotypes associated with the homozygous *duox* mutants, we wondered whether T~4~ treatment also diminished the size of the thyroid gland in the *duox* mutants. Anecdotally, we had noted that one of the homozygous *duox sa9892^−/−^* mutant animals in the treated group had a small external goitre before treatment, but the goitre resorbed after 2 weeks of treatment. In comparison, a homozygous mutant sibling in the untreated group, that also had an external goitre, showed an increase in the size of the goitre during the course of the experiment (data not shown). This suggested that T~4~ treatment might lead to a diminution in the size of the thyroid glands in the homozygous mutant animals. To confirm whether this was the case, we sectioned and performed ISH for *thyroglobulin* on some of the treated and untreated homozygous mutant animals. We found that treatment led to a dramatic decrease in the thyroid hyperplasia normally associated with the *duox* homozygous mutants. However, some of the treated animals did retain some small areas of ectopic *thyroglobulin* staining in the head not seen in WT animals, suggesting that these animals had extensive ectopic thyroid follicular tissue prior to treatment ([Fig. 7](#BIO037655F7){ref-type="fig"}H--J).

Methimazole phenocopies *duox* mutant phenotypes {#s2h}
------------------------------------------------

For final confirmation that the phenotypes found in the homozygous *duox* mutants were due to hypothyroidism, we asked whether exposure of WT fish to the goitrogen methimazole (1 mM) phenocopied the homozygous mutant phenotypes. To counter the influence of already circulating THs, we exposed the adult fish over a 3-month period. Treated animals became darker, owing to an increase in the number of melanophores ([Fig. 8](#BIO037655F8){ref-type="fig"}A--C). In addition, adult fish treated with methimazole failed to breed, as observed among homozygous *duox* mutant animals. They also developed external goitres (three out of seven) ([Fig. 8](#BIO037655F8){ref-type="fig"}F) and, internally, their thyroid follicles spread dramatically in area ([Fig. 8](#BIO037655F8){ref-type="fig"}G,H). This was reminiscent of the observations made in homozygous *duox* mutants ([Fig. 8](#BIO037655F8){ref-type="fig"}I). Finally, WT larval zebrafish continuously treated with methimazole from between 3 hpf and 5 hpf onwards showed resistance to follicular T~4~ immunostaining, similar to that found in *duox sa9892^−/−^* and *duox sa13017^−/−^* mutant larvae ([Fig. 8](#BIO037655F8){ref-type="fig"}D,E). Fig. 8.**The goitrogen methimazole** **(MMI) phenocopies *duox* mutations.** A and B show a 5× magnification of the distribution of melanophores on the flank region among MMI-treated and untreated WT fish. Treated animals have at least two distinct populations of melanophores, based on size (A,B). Pigment change pertaining to melanophore numbers is significant following MMI treatment (C). (Bonferroni\'s multiple comparisons \*\**P*\<0.01). MMI leads to loss of bound T~4~ in WT larvae (D,E) and induces external goitre (arrowhead; F). ISH for thyroglobulin reveals widespread follicular tissue, not limited to the mid-ventral region (H), similar to *duox* mutants (I). Scale bars: 1 mm.

DISCUSSION {#s3}
==========

The zebrafish has recently emerged as a new, genetically tractable model for investigating the molecular mechanisms underpinning thyroid organogenesis and function ([@BIO037655C1]; [@BIO037655C22]; [@BIO037655C26]; [@BIO037655C49]; [@BIO037655C77]; [@BIO037655C81]). Although a recent report described the larval phenotype associated with CRISPR generated bi-allelic loss-of-function *duox* mutations in F0 zebrafish ([@BIO037655C77]), there have been no prior reports describing the phenotypic consequences of fully characterised *duox* alleles in adult zebrafish. This is despite the fact that mutations in *DUOX2* and *DUOX1* have been shown to be associated with congenital hypothyroidism in humans for more than a decade ([@BIO037655C4]; [@BIO037655C19]; [@BIO037655C37]; [@BIO037655C39]; [@BIO037655C42]; [@BIO037655C75]; [@BIO037655C79]). Here, we describe a comprehensive assessment of the adult phenotypes associated with homozygosity of two loss-of-function alleles of zebrafish *duox* in adult fish. The additional round of genome duplication in teleost fish ([@BIO037655C74]) notwithstanding, there only exists a single orthologue of *duox* in zebrafish, instead of the two orthologues present in tetrapods (*DUOX1* and *DUOX2*) ([@BIO037655C40]). Remarkably then, in this instance, zebrafish has less genetic redundancy for this gene than is commonly found in this system. Thus, assessing phenotypes associated with homozygosity of the single *duox* orthologue in zebrafish has allowed us to model the effect of losing the function of both *duox* orthologues in tetrapods. This is particularly important as mutations in both *DUOX1* and *DUOX2* in humans have been associated with a more severe form of CH ([@BIO037655C4]), suggesting that *DUOX1*, while normally playing a minor role in TH synthesis in humans, does partially compensate for the loss of *DUOX2* in humans.

Amongst the various adult phenotypes displayed by the homozygous *duox* mutants, most have been previously observed following pharmacological disruptions in thyroid hormone synthesis or in mutant strains where the hypothalamic--pituitary--thyroid (HPT) axis in zebrafish is affected. For example, goitrogen treatments, thyroid ablation and *tshr* mutant strains display alterations in pigmentation ([@BIO037655C49]), similar to those we found in homozygous *duox* mutants. More specifically, thyroid ablated zebrafish have a darker striped pattern due to an increase in the density of melanophores within each stripe ([@BIO037655C49]), akin to our homozygous *duox* mutants. Another notable phenotype in our homozygous mutants reminiscent of prior findings in goitrogen-treated zebrafish was erythema in the proximity of the operculum. [@BIO037655C64] came across a striking histopathological phenotype following treatment of WT zebrafish with the goitrogen, phenylthiouracil (PTU) ([@BIO037655C22]), wherein treatment resulted in excessive proliferation of blood vessels surrounding the thyroid follicles. This proliferation is attributed to hyperemia resulting from blood aggregation in proximally swollen blood vessels surrounding the thyroid follicles and is concentration-dependent, with the highest concentrations leading to hyperemia ([@BIO037655C64]). Macroscopically, this proliferation of vasculature manifests as erythema, giving a red colour to the entire opercular region. While we did not perform a histological examination of the vasculature, our macroscopic observations are consistent with these reported findings, with all our mutants displaying this conspicuous redness of the opercular region. The colouration was most notable amongst younger animals and especially apparent in backgrounds lacking melanophores. Space constraints together with follicular expansion and vascular proliferation in the pharyngeal region could also explain for the flaring opercula observed in some mutants, although this could also be due to thyroid hyperplasia, which was also noted by [@BIO037655C64] in their PTU-treated fish.

We were also able to induce this chronic hypothyroid/goitrogenic state in WT animals following treatment with methimazole, resulting in similar phenotypic outcomes. In our reverse experiment, however, it was very interesting to note that while T~4~ treatment of mutants resolved the goitres, some follicular staining remained in ectopic regions. Even so, the overall amount of thyroid tissue was largely diminished. It has been reported that at concentrations ≥25 mg/l of PTU, follicular encroachment is found in the gills of zebrafish, suggesting ectopic follicular expansion ([@BIO037655C64]). Follicular expansion following exposure to methimazole is attributed to thyroid hyperplasia, both, in zebrafish ([@BIO037655C64]) and in frog tadpoles ([@BIO037655C33]). This is regarded to be the first step in compensating for TH production via TSH ([@BIO037655C64]). Concentration dependent increases in the extent of follicular hypertrophy and hyperplasia have also been reported in the fathead minnow (*Pimephales promelas*), when exposed to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole ([@BIO037655C54]). *duox* mutants and methimazole-treated WTs presented with amplified *thyroglobulin* expression that showed follicular crowding in the pharyngeal regions and invasion in other ectopic locations. Thyroid dyshormonogeneis (TD) is among the leading causes of CH, and ectopia (ectopic thyroid) is the commonest subtype of TD ([@BIO037655C17]). Ectopic thyroid glands have recently been reported in human *DUOX2* mutations wherein scintigraphy revealed submandibular and sublingual thyroid ectopic locations ([@BIO037655C42]).

Teleost fins have garnered interest within the scientific community not only due to their extensive morphological diversity, but also due to their remarkable regenerative capacities ([@BIO037655C38]; [@BIO037655C53]). Fins are composed of multiple branched and multi-segmented rays covered in a thin layer of epidermal cells. Individual rays consist of a pair of hemirays. Mature hemirays, known as lepidotrichia, are surrounded by a monolayer of osteoblasts that synthesise the bone matrix. With no musculature present, the remainder is made up of mesenchymal cells with nerve fibres and vasculature running along and inside the fin rays. Because of the constant growth, renewal and maintenance of the fins, it is relatively uncommon to find animals in aquaria with damaged fins ([@BIO037655C84]). Thus, the ragged fins in the *duox* mutants stand out. We have found that the presence of ragged fins is ameliorated, however, by treatment of the mutants with T~4~. Our observations are in line with those in the medaka (*Oryzias latipes*) hypothyroidism mutant, *kmi^−/−^*, which also frequently exhibit damaged or ragged fins ([@BIO037655C66]). Furthermore, *kmi^−/−^* animals have also been reported to show delayed regeneration, which can be rescued via exogenous T~4~.

CH has been associated with cephalic and facial defects and developmental neurological abnormalities ([@BIO037655C23]). Such defects have been attributed to improper development of the cranial neural crest (CNC), which is a transient population of migratory embryonic stem cells. Arising from the neural ectoderm, these cells contribute to a long list of cell types, including bone, cartilage, craniofacial connective tissue, corneal stroma and endothelium, iris stroma, ciliary body stroma and muscles, sclera and the trabecular meshwork of the eye ([@BIO037655C5]; [@BIO037655C50]). An investigation of craniofacial morphogenesis using rats exposed to methimazole revealed a 25% reduction in the overall head size throughout gestation ([@BIO037655C23]). These findings are consistent with observations on craniofacial shape in zebrafish *manet^wp.r23e1^* mutants as well as metronidazole-mediated thyroid ablated transgenics *Tg(tg:nVenus-2a-nfnB)^wp.rt8^*, which have narrower heads than controls ([@BIO037655C49]). Further evidence on the role of THs has been gathered using pharmacological and morpholino-based approaches in zebrafish larvae. In one study, methimazole treatment resulted in reduced head depth and shorter jaw length ([@BIO037655C48]). In another study, methimazole and PTU were found to inhibit pharyngeal arches and ceratohyal cartilage development, while knockdown of *thraa* (thyroid receptor α a) led to malformations in the Meckel's and ceratohyal cartilages ([@BIO037655C7]). Our observations of the shorter frontal height among *duox sa9892^−/−^*, *sa13017^−/−^* and *sa9892/sa13017* animals are yet another indicator of TH deficiency.

Furthermore*, duox* mutants appear to experience several phenotypes associated with retarded growth and development. These include delayed growth rate, and delayed or incomplete swim bladder morphogenesis and barbel emergence. As development is underway, fish standard length (SL) is subject to both genetic and environmental factors, thus introducing variation amongst siblings. Indeed, environmental influences on SL is clearly apparent as larvae reared in groups show greater variation in SL than larvae raised individually ([@BIO037655C57]). SL is, thus, regarded as a more reliable measure of fish maturation than age ([@BIO037655C57]; [@BIO037655C68]). Considering the mean values for SL for our groups, it was clearly apparent that at 3 months of age all mutant groups were significantly shorter (i.e. less mature) than their heterozygous or WT siblings. Remarkably, by 6 months, however, the homozygous *duox* mutant fish caught up with the WT and heterozygotes siblings. This suggests that it is not growth per se, but the state of maturation, which is dependent on thyroid hormones. This finding is consistent with findings in non-metamorphosing *Xenopus laevis* tadpoles, which become giants and can live for years in an immature neotenic state ([@BIO037655C62]). This arrested development, associated with continued growth, has been attributed to a lack of thyroid glands in these animals ([@BIO037655C62]). In fish, definitive evidence of TH insufficiency causing metamorphic stasis is well appreciated from studies on flatfish. Larvae of the summer flounder (*Paralichthys dentatus*), when treated with thiourea, do not develop beyond early metamorphic climax ([@BIO037655C65]). Likewise, olive flounder (*Paralichthys olivaceus*) larvae treated with the goitrogen, thiourea, enter metamorphic stasis and become giant larvae ([@BIO037655C36]). Although metamorphosis among the roundfish is less dramatic, several examples illustrate the dependence of metamorphosis on THs. Thiourea treatment was found to arrest metamorphosis in the coral trout grouper (*Plectropomus leopardus*) ([@BIO037655C76]), orange-spotted grouper (*Epinephelus coioides*) ([@BIO037655C18]) and the red sea bream (*Pagrus major*) ([@BIO037655C29]). Meanwhile, the pesticide chlorpyrifos, reported to cause reductions in serum concentrations of T~4~ and T~3~ ([@BIO037655C69]), was recently found to prevent metamorphic completion in the convict surgeonfish (*Acanthurus triostegus*) ([@BIO037655C31]). In zebrafish, a 1 mM concentration of methimazole inhibited the larval to juvenile transition ([@BIO037655C8]). However, larvae treated with a concentration of 0.3 mM eventually escaped the inhibition and continued development. While our *duox* mutants eventually reach normal adult size, this might be associated with an incomplete metamorphic or immature state. Alternatively, there may be some genetic redundancy present in zebrafish, whereby a different source of H~2~O~2~ in the thyroid follicles might be capable of partially compensating for the loss of *duox* function. Indeed, another NOX isoform, NOX4, has been described in human thyrocytes. Unlike Duox though, NOX4 generates H~2~O~2~ in the intracellular compartment ([@BIO037655C82]). It may thus be important to generate double mutants for *duox* and *nox4* to determine the contribution of Nox4 in thyroid hormonogenesis.

In the zebrafish, swim bladder inflation is dependent on THs ([@BIO037655C25]; [@BIO037655C48]). The posterior chamber of the swim bladder inflates around 4.5 dpf while the anterior chamber inflates by 21 dpf ([@BIO037655C85]). These events appear to coincide with peaks in whole body T~3~ at 5 dpf and 10 dpf and T~4~ at 21 dpf ([@BIO037655C12]). Previously, it was found that swim bladder inflation was significantly delayed in thyroid-ablated zebrafish, where the anterior chamber of the bladder inflated ∼50 dpf, compared to ∼20 days in controls ([@BIO037655C49]). Similar observations were also made in thyroid-ablated *Danio albolineatus* ([@BIO037655C49]). There also exists sufficient evidence of how pharmacologically disrupted thyroid processes affect swim bladder inflation. Ecological assessments of aquatic pollutants often employ key morphological events during fish development as predictive approaches. 2-Mercaptobenzothiazole (MBT), commonly used for rubber vulcanization, is found to occur in environmental water bodies. MBT is a potent TPO inhibitor and its role was recently examined in swim bladder inflation in the fathead minnow (*Pimephales promelas*) ([@BIO037655C54]) and zebrafish ([@BIO037655C71]). Among minnows, larvae continuously exposed to MBT showed a concentration-dependent decrease in anterior lobe size ([@BIO037655C54]). Meanwhile, MBT-treated zebrafish larvae were reported to fare worse than minnows, where 22% of larvae exposed to the highest concentration failed to inflate the anterior chamber ([@BIO037655C71]). Interestingly, even though both species belong to the order Cypriniformes, a compensatory T~4~ response has been reported in the fathead minnow at 21 dpf ([@BIO037655C54]) but not in the zebrafish ([@BIO037655C71]), suggesting species-specific differences. Our homozygous *duox* mutant animals also displayed a significant delay in anterior chamber inflation, suggesting that Duox is essential for this process, likely through its role in thyroid hormone synthesis.

Barbels are yet another easily observable phenotypic trait influenced by thyroid hormones. In zebrafish, both pairs develop as epithelial buds around 30--40 dpf, following the emergence of pelvic fin rays ([@BIO037655C27]; [@BIO037655C57]). Thus far, only one study has reported barbel emergence to be influenced by THs. Thyroid ablation via Mtz of *Tg(tg:nVenus-2a-nfnB)* of *Danio rerio* and *D. albolineatus* resulted in the absence of sensory barbels ([@BIO037655C49]). Similarly, *manet* mutants were also found to lack barbels ([@BIO037655C49]). Our homozygous *duox* mutants also show impairment of barbel emergence, consistent with their hypothyroid state. However, it is notable that a subset of the *sa9892^−/−^* mutants eventually did grow barbels, similar to their body length catch-up phenotype.

In humans, thyroid dysfunction during pregnancy has been positively associated with adverse maternal/foetal outcomes, including infertility, miscarriage, pre-eclampsia, pre-term (before 37 weeks) birth and maternal thyroid dysfunction postpartum ([@BIO037655C28]; [@BIO037655C70]; [@BIO037655C78]). TH is essential for early development and maturation of the foetal brain and maternal transfer of TH is especially important during the first trimester ([@BIO037655C14]) since the embryo does not begin synthesising THs until 12--13 weeks into gestation ([@BIO037655C10]). The British Thyroid Foundation suggests prescribing levothyroxine to hypothyroid women trying to conceive in order to address these negative consequences of hypothyroidism on fertility and pregnancy. Intriguingly, we also noted significant defects in fertility in both sexes in our homozygous *duox* mutants. Although we do not currently know the reason for infertility in the *duox* mutants, a potential cause may be due to failure in mating behaviour as a consequence of the observed effects on pigmentation in the mutants. It has previously been noted that, in zebrafish, both sexes experience diurnal changes in their stripes and interstripe colours, a process termed ephemeral sexual dichromatism, during mating and spawning ([@BIO037655C35]). Another study reported that females utilise yellow colouration for sex recognition ([@BIO037655C34]). This ties in well with xanthophore deficiency reported in thyroid ablated, hypothyroid zebrafish ([@BIO037655C49]), and by extension, the *duox* mutants. However, it is notable that casper strains of zebrafish, which lack xanthophores altogether, can successfully breed ([@BIO037655C83]). Thus, there may be additional factors that may be contributing to infertility in *duox* mutants.

Associations between thyroid status and reproduction in teleosts have been previously reviewed ([@BIO037655C15]). Four physiological pre-requisites have been recognised as essential to spawning behaviour and fertility in fish: (1) the completion of vitellogenesis in the ovaries, (2) maturation and ovulation of oocytes stimulated by pituitary luteinizing hormone (LH), (3) completion of spermatogenesis, and (4) sufficient production and storage of milt (seminal plasma and mature sperm) in the sperm duct. These are largely regulated by the endocrine system ([@BIO037655C88]). T~3~ enhances the response of the ovarian follicles to gonadotropins, thus facilitating secretion of 17β estradiol ([@BIO037655C87]). This regulates the production of vitellogenin by the liver, and in studies on Great Lakes salmonids it has been suggested that lowered T~3~ levels may impair oocyte production ([@BIO037655C44]). In the fathead minnow (*Pimephales promelas*), Methimazole treatment led to a reduction of the cortical alveolus oocytes, relative to control females. Meanwhile, in post-spawning males, control animals showed an increase in the number of spermatozoa and a decrease in the number of spermatogonia. This increase in spermatozoa was not observed in methimazole-treated cohorts, suggesting that hypothyroidism affects spermatogenesis ([@BIO037655C46]). Among the African sharptooth catfish (*Clarias gariepinus*), pre-spawning males treated with thiourea were shown to have narrower seminiferous tubules and fewer spermatozoa ([@BIO037655C73]). Intriguingly, hypothyroidism in humans has also been associated with impaired spermatogenesis and sperm abnormalities ([@BIO037655C43]). We have found that fertility in our homozygous *duox* mutants can be restored in both sexes and we can successfully raise offspring to adulthood from a cross between a mutant male and WT female. This is in line with previous observations on growth-retarded (*grt*) mice. *grt* mice have autosomal recessive hypothyroidism, with females suffering lifelong infertility and males gradually acquiring fertility. When treated with THs, *grt* females showed an increase in the size of their uteri and ovaries, which was comparable with heterozygous and WTs. Furthermore, they engaged in copulatory behaviour and were able to conceive and deliver pups ([@BIO037655C32]). Zebrafish *duox* mutants thus provide an excellent model to investigate the consequences of human CH associated with mutations in *DUOX1* and *DUOX2*, and the mechanisms by which treatment with THs, even in adults, can restore many of the defects caused by chronic hypothyroidism, including restoration of fertility in both males and females.

Conclusion {#s3a}
----------

Overall, we found that homozygous mutants display a number of phenotypes, which can be ascribed to hypothyroidism, including growth retardation, pigmentation defects, ragged fins, thyroid hyperplasia and external goitre. By and large, the growth retardation defect is not permanent, as fish continue to grow despite being chronically hypothyroid, and ultimately catch up with their euthyroid heterozygous and WT siblings. This contrasts with findings in humans suffering from hypothyroidism, who remain growth retarded unless T~4~ treatment is initiated within weeks after birth. Most other phenotypes associated with chronic hypothyroidism in the *duox* mutant fish were rescued by T~4~ treatment, even if supplementation was not initiated until adulthood. These include recovery of fertility, return to normal pigmentation, improvement in fin morphology and return to normal size thyroid glands. In summary, *duox* mutant zebrafish provide a new and potentially powerful system to understand the consequences of chronic congenital hypothyroidism on growth and maintenance of body physiology, as well as the mechanisms of recovery of normal physiology following thyroid hormone supplementation. Thus, our *duox* mutant fish appear to be in a chronic hypothyroid/goitrogenic state, as indicated by their external goitres as well as internal expansion of *thyroglobulin* expressing tissue.

MATERIAL AND METHODS {#s4}
====================

Ethics statement {#s4a}
----------------

All experiments involving animals were approved by the local ethics committee and the Home Office.

Animals and husbandry {#s4b}
---------------------

Adults and larvae were used in this study. The zebrafish (*D. rerio*) WT line used was AB. Mutant lines used were *duox sa9892* and *duox sa13017* ([@BIO037655C41]) and were obtained from the European Zebrafish Resource Center (EZRC). Compound heterozygotes for these mutant alleles were generated in-house. Both *duox* alleles were also crossed into *nacre* (*nac^w2^*) ([@BIO037655C47]) and *casper* ([@BIO037655C83]) strains for visualising larval thyroid follicles, swim bladder and adult erythema. In all cases, embryos were raised in sea salts (Sigma-Aldrich, S9883) medium containing 0.0001% Methylene Blue until 5 days post-fertilisation (dpf) and then transferred to the system where they were maintained at a temperature of 28°C, pH 7.4, constant salinity and a 14:10 photoperiod.

PCR and genotyping {#s4c}
------------------

Genomic DNA was extracted from caudal fin clips or whole larvae using lysis buffer, in a thermal cycler. The conditions for this procedure were 2 h at 55°C, 10 min at 95°C and a hold (if necessary) at 12°C. PCR was performed using ExTaq DNA polymerase (TaKaRa RR001A) with the following primer pairs: for the *duox sa9892* allele, forward 5′-ACGAGGTACACAACTCAAGCTG-3′ and reverse 5′-GACGTTCAAAGCGAAACCTGAC-3′; for the *duox sa13017* allele, forward 5′-TGGTACACCATTTGAGGATGTGA-3′ and reverse 5′-ACACCCACCATAGAGGTCTCT-3′. PCR conditions were as follows: 36 cycles at 94°C for 30 s, 55°C for 30 s and 72°C for 30 s. Samples were subject to Sanger sequencing (GATC Biotech). Sequencing primers used were 5′-CTTGGTCTGCCTTTGACGAAGT-3′ for the *duox sa9892* allele and 5′-GTGACTCAAGTCAGAACAGGTC-3′ for the *duox sa13017* allele. Siblings were stage-matched, phenotypically WT, heterozygous and homozygous animals obtained by crossing heterozygous carriers.

Whole mount immunofluorescence {#s4d}
------------------------------

Zebrafish larvae, at 5 dpf, were fixed overnight in 4% phosphate-buffered paraformaldehyde (PFA) (Sigma-Aldrich), at 4°C. This was followed by 15 min of dehydration in 100% methanol. Larvae were then transferred to fresh 100% methanol and stored at −20°C until usage. Larvae were gradually rehydrated to PBST, treated with 10 µg/ml proteinase K (Roche) for 30 min, briefly rinsed in PBST, and postfixed in 4% PFA for 20 min. Following further rinsing in PBST, larvae were immersed in blocking buffer (PBST containing 1% dimethylsulfoxide, 1% BSA, 5% horse serum and 0.8% Triton X-100) for 2 h. This was followed by overnight incubation, at 4°C, in blocking buffer containing the primary antibody (1:1000) against thyroxine (T~4~) (Biorbyt orb11479). Overnight incubation was followed by several wash steps in PBST containing 1% BSA. Larvae were then incubated overnight, at 4°C, in blocking buffer containing the secondary antibody (1:250) Alexa Fluor 568 (Invitrogen A11057) ([@BIO037655C56]). Stained larvae were washed in PBST, imaged and then subject to genotyping.

Histology and ISH {#s4e}
-----------------

*In situ* hybridization on sections of adult zebrafish was performed essentially as described ([@BIO037655C58]). Briefly, adult zebrafish were fixed whole in 4% PFA for 1 week followed by a decalcification step in 20% EDTA, for 10 days. Animals were then cut at the operculum and mid trunk level and processed in a Leica TP1050 tissue processor in preparation for paraffin embedding. The embedding station used was a Leica EG1150H. The cut face of the tissue was oriented towards the leading edge of the paraffin block and sectioned at 5 μm thicknesses on a LeicaRM2255 microtome. Sections were arranged and held on Superfrost Plus™ slides (Thermo Fisher Scientific). Alternating sections were then taken forward for Haematoxylin and Eosin (H&E) staining and ISH. Sections were put through H&E staining via a Varistain 24-4 carousel (Thermo Fisher Scientific, Shandon). *Thyroglobulin* (*tg*) cDNA used for riboprobe synthesis was amplified using forward 5′-AGGTGGAGAATGTTGGTGTG-3′ and reverse 5′-CTCCAACTCTGGCAATGACT-3′ primers. Digoxigenin-labelled probes were synthesised *in vitro* using a MEGAscript®T7 kit (Ambion).

Body length and melanophore counts {#s4f}
----------------------------------

For measuring body length, all fish were briefly anaesthetised in 0.02% MS 222 (tricaine) (Sigma-Aldrich). They were then transferred onto an agarose bed in a petri dish and imaged at 0.73× magnification. For each fish two or three images were captured in order to include the entire length including the caudal fin. These part images were stitched together in Adobe^®^ Photoshop to obtain a single image. The 'ruler' tool and 'analyse measurement' command in Photoshop CS5 were used on these images to calculate the length from the tip of the mandible to the caudal peduncle.

For determining melanophore density, all fish were treated with epinephrine to contract pigment granules. To obtain a 1 mg/ml working solution, 0.1 g of epinephrine was dissolved into 100 ml of a 0.01% tricaine solution. Epinephrine is only partially soluble in water and thus, the solution was filtered to obtain a clear filtrate. The solution turns pink-orange during filtration. Fish were treated for 5 min in this working solution. They were then transferred onto an agarose bed in a petri dish and imaged at two locations on the lowermost continuous stripe extending from the operculum to the trunk. A 5× magnification was used. The 'multi-point' tool on FIJI was used to manually count all melanophores contained within a stripe, in the field of view, for each image. All images were acquired on a Leica MZ16FA fluorescence stereomicroscope with a DC490 camera.

Pharmacological treatments {#s4g}
--------------------------

For rescuing mutant phenotypes, a 12-week treatment with T~4~ (Sigma-Aldrich) was sustained in a closed system that closely resembled aquarium conditions. Four groups- *sa9892^+/−^* untreated, *sa9892^+/−^* treated, *sa9892^−/−^* untreated and *sa9892^−/−^* treated were subject to this regime, with each group comprised of four adult fish. T~4~ was added tri-weekly, at a concentration of 30 nM. Water was changed three times each week.

For phenocopy experiments, a 12-week treatment with methimazole (Sigma-Aldrich) was administered, once again, in a closed system simulating aquarium conditions. This regime was applied to six WT adult fish, while six untreated WT animals comprised the control group. Methimazole was added tri-weekly, at a concentration of 1 mM. Water was changed three times each week.

For immunostaining, WT larvae were treated with methimazole (0.3 mM) from 0 dpf. Animals were then fixed at 5 dpf and stained for T~4~ as described above.

Statistical analyses {#s4h}
--------------------

GraphPad Prism 7 was used for statistical testing. Column statistics and analyses of variance were implemented for all data sets. For column statistics, we calculated median, s.d., s.e.m., confidence intervals and Gaussian distribution. The D\'Agostino and Pearson test was used to check for Gaussian distribution. One-way ordinary ANOVA was used to analyse variance. Differences were considered significant at *P*\<0.0001. Bonferroni\'s multiple comparisons test was used to compare means between groups.
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